FDA Launches Campaign Against Teenage Smokeless Tobacco Use

FDA Launches Campaign Against Teenage Smokeless Tobacco Use

Government health officials will team up with minor league baseball as part of a new $36 million campaign to discourage rural teenagers from using chewing tobacco.

Baseball stadiums will feature the campaign’s central message this summer – “smokeless doesn’t mean harmless” – via advertising and promotions with players. Ads will also run on local television, radio and online in 35 markets across the U.S., including cities in Michigan, Montana, South Carolina and Tennessee.

The Food and Drug Administration says its latest effort targets white, rural males who are more likely to use dip, chew and other smokeless tobacco products. Roughly 32 percent of rural males ages 12 to 17, or roughly 629,000 Americans, are at-risk for using chewing tobacco, according to the agency.

FDA’s Mitch Zeller, director of the agency’s tobacco program, said smokeless tobacco is culturally ingrained in many rural communities as a “right of passage”.

“Often male teenagers in rural communities are accustomed to seeing smokeless tobacco use among role models, such as their fathers and grandfathers, older brothers and community leaders,” he told reporters.

Related Post

COVID-19 Update | FDA News Release | FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19.
Urgent Family Care blog fallback

Coronavirus (COVID-19) | FDA News Release | FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection.
Urgent Family Care blog fallback

FDA Approves AspireAssist Device to Treat Obesity

The FDA has approved a surgically implanted weight-loss device that drains the contents of the stomach after meals.